Vancomycin Clearance During CVVHDF With an oXiris Membrane: Pharmacokinetic Evidence of Adsorptive Drug Removal
Blood Purification · 21.11.2026
DOI: 10.1159/bpu/abpag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, online erschienen am 21.11.2026. Verfasst von Konstantinos Ioannidis und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
Adsorptive hemofilters such as oXiris are increasingly used during continuous renal replacement therapy (CRRT) in septic shock, yet their interaction with antimicrobial agents remains insufficiently characterized. Vancomycin dosing during CRRT is particularly challenging because of altered volume of distribution, protein binding, and extracorporeal clearance. Clinical data describing the magnitude and time course of vancomycin adsorption by oXiris are scarce.
Methods
We performed an in vivo pharmacokinetic/pharmacodynamic (PK/PD) assessment of vancomycin in an anuric, profoundly hypoalbuminemic patient with septic shock undergoing continuous veno-venous hemodiafiltration (CVVHDF) using an oXiris membrane. Serial pre-filter, post-filter, and effluent samples were obtained during the seventh vancomycin dose while the membrane had been in use for 18 hours. Pharmacokinetic parameters, effluent saturation coefficients, pre-dilution-corrected extracorporeal clearance, and vancomycin exposure were estimated using a one-compartment model. Circuit-level concentration patterns were evaluated as observations compatible with, but not definitive quantification of, an adsorptive contribution.
Results
Pre- to post-filter vancomycin concentration reductions declined over time (≈13.5% at 2 hours, 13.3% at 4 hours, and 3.1% at 7 hours), a pattern compatible with a time-dependent adsorptive contribution, although adsorption could not be quantified separately from diffusion and convection. The mean effluent saturation coefficient was 0.62. After first-order correction for pre-dilution, estimated CVVHDF-related clearance was approximately 1.25 L/h. Total clearance was estimated at 5.7 L/h, yielding a model-derived AUC24 of 526 mg·h/L and an AUC24/MIC ratio of 1,053.
Conclusions
In this single patient receiving pre-dilution CVVHDF with an 18-hour-old oXiris membrane, mixed extracorporeal vancomycin removal was observed. After first-order correction for pre-dilution, estimated CLCVVHDF was approximately 1.25 L/h. The temporal circuit pattern was compatible with an adsorptive contribution, but adsorption could not be quantified separately from diffusion and convection. Dose adjustment after membrane replacement should be guided by AUC-based therapeutic drug monitoring rather than applied routinely.
Zitieren
APA
Ioannidis, K., NIKOLAOU, K., O'Jeanson, A., Katsouda, E., Markesinis, D., Galani, L., Paskalis, H., Giamarellou, H., Friberg, L. E., & Karaiskos, I. (2026). Vancomycin Clearance During CVVHDF With an oXiris Membrane: Pharmacokinetic Evidence of Adsorptive Drug Removal. Blood Purification. https://doi.org/10.1159/bpu/abpag034
Vancouver
Ioannidis K, NIKOLAOU K, O'Jeanson A, Katsouda E, Markesinis D, Galani L, et al. Vancomycin Clearance During CVVHDF With an oXiris Membrane: Pharmacokinetic Evidence of Adsorptive Drug Removal. Blood Purification. 2026. doi:10.1159/bpu/abpag034
BibTeX
@article{Ioannidis2026,
author = {Ioannidis, Konstantinos and NIKOLAOU, KATERINA and O'Jeanson, Amaury and Katsouda, Emmanouela and Markesinis, Dimitrios and Galani, Lambrini and Paskalis, Harris and Giamarellou, Helen and Friberg, Lena E. and Karaiskos, Ilias},
title = {Vancomycin Clearance During CVVHDF With an oXiris Membrane: Pharmacokinetic Evidence of Adsorptive Drug Removal},
journal = {Blood Purification},
year = {2026},
doi = {10.1159/bpu/abpag034}
}
EUVIMED